Physical Activity in Patients With Inflammatory Bowel Disease: A Narrative Review

Author(s):  
Maitreyi Raman ◽  
Vidya Rajagopalan ◽  
Sandeep Kaur ◽  
Raylene A Reimer ◽  
Christopher Ma ◽  
...  

Abstract Background Despite advancement in the treatment of inflammatory bowel disease (IBD), induction and maintenance of remission remain challenging to achieve in many patients and a significant proportion of patients with IBD experience mental health conditions, including anxiety, depression, and fatigue, which impair their quality of life (QoL). We aim to describe the available evidence regarding the effects of physical activity (PA) on the onset of IBD, its disease course, and important patient-reported outcome measures (PROMs), such as QoL, fatigue, and mental health. Methods A literature search was performed using electronic databases to identify original articles that assessed the effects of PA in patients with IBD using PROMs. Results Prospective cohort and case-control studies demonstrate inverse relationships between PA and new-onset IBD in Crohn’s disease but not in ulcerative colitis; however, they have small sample sizes and caution must be taken in considering associations versus causation. Small randomized controlled trials suggest promise for PA and beneficial outcomes, such as maintenance of clinical remission and improvement in QoL, fatigue, depression, and anxiety. However, these studies were small and underpowered, and limited by outcome measurements and durations of follow-up. Conclusions Physicians may consider discussing PA interventions with their patients on an individual basis, especially if they report impaired QoL, fatigue, depression, or anxiety, until disease-specific guidelines are available. Including PA as part of a primary prevention strategy in high-risk patients could be considered.

2020 ◽  
Vol 43 (2) ◽  
pp. 172-185
Author(s):  
Lisa S. Olive ◽  
Catherine A. Emerson ◽  
Eliza Cooper ◽  
Emily M. Rosenbrock ◽  
Antonina A. Mikocka-Walus

2014 ◽  
Vol 28 (10) ◽  
pp. 536-542 ◽  
Author(s):  
Wael El-Matary

Patient-reported outcome measures (PROMs) are increasingly used in both research and clinical health settings. With the recent development of United States Food and Drug Administration guidance on PROMs, more attention is being devoted to their role and importance in health care. Several methodological challenges in the development, validation and implementation of PROMs must be resolved to ensure their appropriate utilization and interpretation. The present review discusses recent developments and updates in PROMs, with specific focus on the area of inflammatory bowel disease.


Sign in / Sign up

Export Citation Format

Share Document